International Lymphoma Epidemiology Consortium

Symposium: New Insights Into the Causes of Lymphoma

• Call for Abstracts
• Abstract Guidelines
• Registration Form (pdf)
• For information regarding accommodations, contact Claire Vajdic (cvajdic@nchecr.unsw.edu.au)

Abstract Guidelines

• Abstracts must be original and written in English
• Maximum length is 350 words excluding title, authors and author affiliations (excess words may not be printed)
• Accepted file formats include - Microsoft Word (.doc), text (.txt) or (.rtf)
• All abstracts must be prepared in Times New Roman 12 point type only
• Title should appear in BOLD CAPITALS at the top of the abstract
• List authors and then their affiliations directly below the title
• Principal author to appear first.
• Omit degrees and titles for all authors
• Surname of author(s) to appear first, followed by initials of first (and middle names)
• Please underline the name of the author who will be presenting the paper
• Use superscript* numbering (1, 2, 3, 4 etc.) to represent the link between author and affiliation
• Include the name of institution/affiliation(s) [incl. city, state and country] below the list of authors. [Do not include street address]
• Use the following subheadings in the body of your abstract: Introduction, Methods, Results, Conclusions
• Single spacing should be used
• Leave one line between paragraphs
• Abbreviations must be spelt out in full at the first mention followed by the abbreviations in parentheses
• Do not use references
• Do not use tables, graphs, footnotes or symbols

Abstract Submission

• Abstract and author details must be submitted as an email attachment to interlymphabstract@nchecr.unsw.edu.au
• Abstracts must be prepared according to the guidelines
• Deadline for receipt of abstracts is 31 March 2008
• Authors should indicate in a covering email one of the following subject areas: Lifestyle and environment, Host and Genetics, Immunity and Infection, Pathology and Survival, Hodgkin’s disease and Multiple myeloma.
• When submitting your abstract details online please indicate your preferred presentation type (ie Oral Presentation or Poster). Please note, there will be strong competition for the relatively few oral presentation slots. Unless otherwise indicated, we will assume that those with a preference for oral presentation will agree to presentation of a poster if decided by the adjudication committee.
• By submitting an abstract for consideration, the presenting author must also intend to register for the conference